<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Metastases":1,
"metastatectomy":1,
"renal cell carcinoma":2,
"Blood loss":1,
"Blood transfusion":1,
"Metastatic spine diseases":1,
"Preoperative embolization":1,
"Spinal tumour surgery":1,
"gene expression":1,
"ovarian cancer":1,
"thyroid hormone":1,
"Cancer de la thyroïde":1,
"Irathérapie":1,
"Quality of life":1,
"Qualité de vie":1,
"Radioiodine therapy":1,
"Thyroid neoplasms":8,
"PER":1,
"adrenal":1,
"brain and muscle ARNT-like 1":1,
"circadian locomotor output cycles kaput":1,
"cryptochrome":1,
"diabetes mellitus":1,
"thyroid":6,
"Completion thyroidectomy":1,
"Hypoparathyroidism":1,
"Postoperative complication":1,
"Total thyroidectomy":4,
"BRAF":1,
"Molecular marker":1,
"RAS":1,
"Thyroid cancer":18,
"Thyroid cytology":1,
"DNER":1,
"Quantum dot-based immunofluorescent imaging":1,
"prognostic value":1,
"prostate cancer":1,
"Lymph node metastasis":2,
"Neck dissection":2,
"Papillary thyroid microcarcinoma":1,
"Risk factors":1,
"Benign and malignant thyroid nodules":1,
"Differential diagnosis":1,
"Intravoxel incoherent motion":1,
"Magnetic resonance imaging":1,
"Multiple b value":1,
"ionizing radiations":1,
"oncological disease,":1,
"probability of causation":1,
"ACR TI-RADS":1,
"BRAF(V600E) mutation":1,
"Hashimoto's thyroiditis":2,
"PTC":2,
"Ultrasound":4,
"Surveillance Epidemiology End Results (SEER)-Medicare":1,
"cancers":1,
"elderly":1,
"sepsis":1,
"Computed tomography":1,
"Retrosternal goiter":1,
"Sternotomy":1,
"Thyroidectomy":5,
"papillary thyroid carcinoma":25,
"parotid gland":1,
"radioactive iodine":1,
"shear wave elastography":1,
"submandibular gland":1,
"alopecia":1,
"areata":1,
"comorbid":1,
"comorbidities":1,
"comorbidity":1,
"prevalence":4,
"risk":2,
"contrast-enhanced ultrasound":2,
"conventional ultrasound":2,
"head and neck":1,
"mummified thyroid nodules":1,
"LINC00152":2,
"brain-derived neurotrophic factor (BDNF)":1,
"miR-497":1,
"papillary thyroid carcinoma (PTC)":1,
"Chemotherapy":3,
"Neoadjuvant":1,
"Pancreatic cancer":2,
"Surgery":1,
"Endoscopic Thyroidectomy":1,
"Minimally Invasive Thyroidectomy":1,
"Remote Access Thyroidectomy":1,
"Robotic Thyroidectomy":1,
"18F-FDG":1,
"2-deoxy-2-(18F)fluoro-D-glucose":1,
"Medullary thyroid carcinoma":2,
"Personalized medicine":1,
"Positron emission tomography":1,
"TKI":1,
"Tyrosine kinase inhibitor":3,
"Vandetanib":2,
"Breast cancer":7,
"CYP3A4 gene":1,
"Polymorphism":2,
"Susceptibility":1,
"Computer-aided diagnosis":1,
"Nodule":1,
"Cell migration":1,
"cell proliferation":1,
"human insulin":1,
"insulin glargine":1,
"case-control study":2,
"cohort study":2,
"depression":1,
"epidemiology":3,
"mood disorder":1,
"Malignancy":3,
"Scintigraphy":1,
"Thallium-201":1,
"Thyroid nodules":4,
"Ultrasonography":4,
"AXL":1,
"DCC-2036":1,
"MET":1,
"PDX":1,
"TNBC":1,
"YY1":2,
"metastasis":5,
"miR-141-3p":1,
"tumor growth":2,
"Nodular recurrence":1,
"Thyroid lobectomy":1,
"cancer":3,
"pregnancy":2,
"pregnancy-associated cancer":1,
"biomarkers":1,
"metabolomics":3,
"non-invasive diagnosis":1,
"thyroid nodule":8,
"primary aldosteronism":1,
"white-coat hypertension":1,
"children":1,
"mucormycosis":1,
"mycoses":1,
"Lateral neck dissection":1,
"Lymph node metastases":1,
"Recurrence of papillary thyroid carcinoma":1,
"Reoperative lateral neck dissection":1,
"Denmark":1,
"incidence":1,
"multiple endocrine neoplasia 2A":1,
"genome-wide association study":1,
"next generation sequencing":1,
"rs116909374":1,
"rs944289":1,
"YWHAZ":1,
"epithelial-to-mesenchymal transition":1,
"gastric cancer":1,
"miR-375":1,
"wnt/β-catenin":1,
"Efficacy":2,
"adverse event":2,
"ovarian function suppression":1,
"tamoxifen":1,
"AJCC":1,
"TNM-8":1,
"differentiated thyroid carcinoma":2,
"gross extrathyroidal extension":1,
"survival":1,
"Amphiphilic nanoparticles":1,
"Near-infrared fluorescence imaging":1,
"Photoacoustic imaging":1,
"Photothermal therapy":1,
"Redox-sensitivity":1,
"Differentiated thyroid cancer":3,
"Excellent response":1,
"Negative 99mTc-pertechnetate uptake":1,
"Radioactive iodine therapy":1,
"FOXQ1":1,
"poor prognosis":1,
"Clear Cell Renal Cell Carcinoma":1,
"FTO":1,
"Prognosis":6,
"TCGA":1,
"DTC":1,
"Neck-to-skull ratio":1,
"Serum thyroglobulin":1,
"Treatment response":1,
"follow-up strategy":1,
"indeterminate response":1,
"ectopic thymus":1,
"fine needle aspiration":1,
"flow cytometry":1,
"thyroid imaging reporting and data system":1,
"ultrasound features":1,
"fibroids":1,
"hysterectomy":1,
"oophorectomy":1,
"Ectopic pituitary tumors":1,
"Extrasellar":1,
"Secretory tumors":1,
"Endothelin axis":1,
"Papillary thyroid cancer":3,
"Cancer cell line encyclopedia":1,
"Forkhead box A":1,
"Lung cancer":2,
"Oncomine":1,
"Agreement":1,
"American College of Radiology Thyroid Imaging Reporting and Data System":1,
"Inter-observer":1,
"Management":1,
"Variability":1,
"architectural atypia":1,
"growth rate":1,
"indeterminate cytology":2,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"fine-needle aspiration cytology (FNAC)":2,
"indeterminate":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"thyroid carcinoma":3,
"Acromegaly":1,
"IGF-1":1,
"Natural course":1,
"Thyroid nodule growth":1,
"Ring1 and YY1 binding protein (RYBP)":1,
"anaplastic thyroid cancer (ATC)":1,
"chemoresistance":2,
"invasion":2,
"proliferation":6,
"Korean":1,
"psoriasis":1,
"MASTL":1,
"Mitotic catastrophe":1,
"Non-oncogene addiction":1,
"Target validation":1,
"Thyroid tumor cells":1,
"Apoptosis":3,
"MDA-MB-231 cell line":1,
"p38γ MAPK":1,
"Cervical spine reconstruction":1,
"Polymethylmethacrylate":1,
"Posterior cervical corpectomy":1,
"Spine metastasis":1,
"Spine tumor":1,
"Kidney cancer":1,
"Spinal metastases":1,
"Treatment algorithm":1,
"Validation study":1,
"Iodine radioisotopes":1,
"receiver operating characteristic":1,
"thyroglobulin":2,
"thyroid carcinoma, non-medullary":1,
"MIBI scintigraphy":1,
"parathyroid adenoma":2,
"washout":1,
"cytology":1,
"fine needle aspiration biopsy":1,
"needle passes":1,
"nondiagnostic rate":1,
"rapid on-site evaluation":1,
"esophageal cancer":1,
"multiple primary cancers":1,
"therapy":1,
"Asymmetric enlargement":1,
"Lacrimal gland":1,
"Thyroid eye disease":1,
"MassARRAY":1,
"heterogeneity":1,
"CCDC6":1,
"microRNA-146b-5p":1,
"Cytological detection":1,
"Intra-operative identification":1,
"Parathyroid glands":1,
"acoustic radiation force impulse":1,
"High mobility group box 1":1,
"miR-let-7e":1,
"microRNAs":1,
"Central compartment":1,
"Complications":1,
"Hypocalcemia":2,
"Nodal metastases":1,
"Vocal fold palsy":1,
"DNA damage":1,
"Di-(2-ethylhexyl) phthalate (DEHP)":1,
"Phthalates":1,
"Thyrotropin receptor (TSH)":1,
"low iodine diet":1,
"radioactive iodine (RAI) ablation":1,
"recombinant human TSH":1,
"urine iodine excretion":1,
"Fukushima nuclear accident":1,
"comparative study":1,
"mass screening":1,
"surgical pathology":1,
"Breast":2,
"Carcinome médullaire thyroïdien":1,
"Métastase":1,
"Neuroendocrine":1,
"Sein":1,
"Dual-tracer":1,
"SPECT/CT":1,
"hyperparathyroidism":1,
"single-photon emission computed tomography":1,
"technetium-99m methoxyisobutylisonitrile":1,
"technetium-99m pertechnetate":1,
"medullary thyroid cancer":1,
"safety":1,
"Cyclic Cushing’s syndrome":1,
"Neuroendocrine tumor":1,
"PDE11A":1,
"Primary pigmented nodular adrenocortical disease (PPNAD)":1,
"anti-angiogenic":1,
"hepatocellular carcinoma":1,
"sorafenib":2,
"Cancer survivors":1,
"Metabolic syndrome":2,
"Major vessel invasion":1,
"extrathyroidal extension":1,
"superior vena cava syndrome":1,
"Monte Carlo method [N05 715 360 750 540]":1,
"radiation exposure [N06 850 460 350 850]":1,
"radiation oncology [H02 403 740 650]":1,
"risk management [N04 452 871]":1,
"tomography":1,
"x-ray computed [E01 370 350 700 810 810]":1,
"HER-2":1,
"clinical and pathological features":1,
"gene amplification":1,
"protein expression":1,
"PTEN":1,
"Triple negative breast cancer":1,
"Tumor progression":1,
"Cancer du sein":1,
"Fonction thyroïdienne":1,
"Hypofractionated radiotherapy":1,
"Radiothérapie hypofractionnée":1,
"Thyroid function":1,
"Bethesda":1,
"Fine-needle biopsy":1,
"elastography":1,
"Posterior pituitary":1,
"Predictive markers":1,
"Somatostatin receptors":1,
"Spindle cell oncocytoma":1,
"MEN1":1,
"concomitant thyroid cancer":1,
"concurrent thyroidectomy":1,
"papillary microcarcinoma":1,
"primary hyperparathyroidism":1,
"cancer overdiagnosis":1,
"imaging tests":1,
"laboratory tests":1,
"overuse":1,
"population-based":1,
"Classification":1,
"Data pre-processing":1,
"Diagnosis of cancer":1,
"Imbalanced data":1,
"Atención sanitaria":1,
"Cáncer de tiroides":1,
"Encuesta de opinión":1,
"Equipo multidisciplinar":1,
"Health care":1,
"Multidisciplinary team":1,
"Opinion survey":1,
"defective ciliogenesis":1,
"dilated and destroyed thyroid follicle":1,
"malignant transformation":1,
"primary cilia":1,
"Age":1,
"Guidelines":1,
"Risk classification":1,
"Postoperative hypoparathyroidism":1,
"Thyroid surgery":2,
"Vitamin D deficiency":1,
"Chimiothérapie":1,
"IORT":1,
"Peropératoire":1,
"Radiotherapy":1,
"Radiothérapie":1,
"Sarcome thyroïdien":1,
"Thyroid sarcoma":1,
"Prognostic factors":2,
"TERT promoter mutations":1,
"GLIS1":1,
"GLIS3":1,
"hyalinizing trabecular tumor":1,
"Checkpoint inhibition":1,
"Immunotherapy":2,
"Microenvironment":1,
"RANK":1,
"RANKL":1,
"Solid tumors":1,
"Aggressive thyroid carcinoma":1,
"Poorly differentiated area":1,
"anaplastic lymphoma kinase":1,
"fusion variants":1,
"oncogene":1,
"resistance mechanisms":1,
"targeted therapy":1,
"colorectal carcinoma":1,
"microRNA-455-5p":1,
"phosphoinositide-3-kinase regulatory subunit 1":1,
"disease-free survival":1,
"matrix metalloproteinase-9":1,
"structurally persistent/recurrent disease":1,
"Lenvatinib":2,
"Side effect":1,
"Follow-up fine needle aspiration":1,
"Follow-up ultrasound":1,
"2015 American Thyroid Association guideline":1,
"Ultrasonographic features":1,
"Endometrial cancer":2,
"Fertility":1,
"Hypothyroidism":2,
"Sex hormone":1,
"Core needle biopsy":1,
"Pathological diagnosis":1,
"High-dose vitamin C":1,
"anticancer effect":1,
"Anaplastic thyroid cancer":1,
"county level median family income":1,
"prognostic factor":1,
"socioeconomic factors":1,
"cancer cell metabolism":1,
"metabolic profile":1,
"oxidative stress":1,
"Mortality":1,
"Recursive partitioning analysis":1,
"TNM staging":1,
"EGFR mutation":1,
"biomarker":2,
"meta-analysis":2,
"non-small-cell lung cancer":1,
"thyroid transcription factor-1":1,
"FRTL5":1,
"PATZ1":1,
"Ras oncogene":1,
"stem cell biology":1,
"thyrospheres":1,
"EMT":1,
"Encapsulation":1,
"Hippo pathways":1,
"Kras":1,
"Nano formulation":1,
"Nkx2 1":1,
"Zeta (ζ) potential":1,
"microRNA-200c":1,
"Hematologic tests":1,
"Lymphocytes":1,
"Neutrophils":1,
"FAL1":1,
"GAS5":1,
"long nonencoding RNA":1,
"Carcinogens":1,
"Exposure":1,
"Neoplasms":1,
"Radon":1,
"Bladder cancer":1,
"Cancer risk":1,
"Oncostatin M receptor":1,
"Polymorphisms":1,
"extragonadal germ-cell tumor":1,
"malignant thyroid teratoma":1,
"radiation":1,
"Radiofrequency ablation (RFA)":1,
"Myotonic dystrophy":1,
"Thyroid goiter":1,
"Ultrasound scan":1,
"Low dose radiation, LDR":1,
"Paired-box domain 8, PAX8":1,
"Thyroglobulin, TG":1,
"miR-330-5p":1,
"tumor location":1,
"Cervical cancer":1,
"Endometriosis":1,
"Melanoma":1,
"Fine needle aspiration cytology":1,
"subcentimetre thyroid nodules":1,
"ultrasound guided":1,
"Carcinoma, squamous cell":1,
"Cyclin-dependent kinase 6":1,
"Laryngeal neoplasms":1,
"BRAF gene mutations":1,
"Langerhans cell histiocytosis":1,
"Metastatic renal cell carcinoma":1,
"Mete-analysis":1,
"Performance status":1,
"CAFs":1,
"GLUT1":1,
"Hypoxia":1,
"Oxidized-ATM":1,
"PKM2(PYKM2)":1,
"cytopathology":1,
"histopathology":1,
"microcarcinoma":1,
"ultrasound-guided fine-needle aspiration biopsy":1,
"bioinformatics":1,
"miRNA":1,
"promoter DNA methylation":1,
"mercury":1,
"cadmium":1,
"lead":1,
"arsenic":1,
"diet":1,
"fingernail":1,
"cross-matched blood":1,
"parathyroid surgery":1,
"lymph node dissection":1,
"recurrence":1,
"surgical complications":1,
"oncology":2,
"public health":1,
"qualitative research":1,
"BNCT":1,
"LC-MS":1,
"MudPIT":1,
"boron":1,
"proteomics":1,
"squamous cell cancer of head and neck":1,
"urine":1,
"T-cell lymphoma":1,
"VEGF":1,
"angiogenesis":2,
"integrin αvβ3":1,
"thyroid hormones":1,
"AZD4547":1,
"Case report":1,
"Fibroblast growth factor receptor":1,
"Thyroid dysfunction":1,
"Urothelial cancer":1,
"ECONOMIC":1,
"MODELS":1,
"NETWORK META-ANALYSIS":1,
"131I therapy":1,
"papillary thyroid micro carcinoma":1,
"risk of recurrence":1,
"Immune Checkpoint":1,
"papillary thyroid carcinomas":1,
"EGCG":1,
"Signaling pathway":1,
"FAM95B1":1,
"UCA1":1,
"lncRNA":1,
"BRAF mutation":1,
"NIFTP":1,
"Thailand":1,
"fine-needle aspiration":1,
"indeterminate thyroid nodules":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"RR-DTC":1,
"TKIs":1,
"adverse effects":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"tyrosine kinase inhibitors":1,
"SAXS":1,
"WAXS":1,
"X-ray scanning microscopy":1,
"aneurysms":1,
"microcalcifications":1,
"microdiffraction":1,
"tissues":1,
"HNSCC":1,
"STOML2":1,
"Stat3":1,
"chemo-sensitivity":1,
"Absorptiometry, photon":1,
"Bone density":2,
"Postmenopause":1,
"Osteoporotic fractures":1,
"Thyrotropin":1,
"Osteoporosis":1,
"diagnostics":1,
"genetic signature":1,
"molecular alteration":1,
"Schwannoma":1,
"intranodal":1,
"lymph node":1,
"neurilemmoma":2,
"spindle cells":1,
"Cachexia":1,
"European Union":1,
"Orphan disease":1,
"USA":1,
"I-131":1,
"fat necrosis":1,
"continuous intraoperative nerve monitoring":1,
"nerve sheath tumor":1,
"vagal schwannoma":1,
"vagus nerve":1,
"Mandible":1,
"NF-κB":1,
"PARP14":1,
"Influenza":1,
"Innate immune system":1,
"Intestinal ischemia reperfusion injury":1,
"Neoadjuvant chemotherapy":1,
"Periodontosis":1,
"Tinnitus":1,
"Cancer-specific mortality":1,
"Radioactive iodide":1,
"CCL28":1,
"breast neoplasms":1,
"subtype":1,
"survival analysis":1,
"18F-FDG PET/CT":1,
"Ectopic thyroid carcinoma":1,
"BRAFV600E":1,
"Bethesda classification":1,
"thyroid imaging reporting and data system (TIRADS)":1,
"H3K18Ac":1,
"HATs":1,
"HDACs":1,
"cancer hallmarks":1,
"histone acetylation":1,
"histone deacetylation":1,
"haematology (drugs and medicines)":1,
"haematology (incl blood transfusion)":1,
"skin cancer":1,
"unwanted effects/adverse reactions":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年2月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
